1. Home
  2. BNR vs INTT Comparison

BNR vs INTT Comparison

Compare BNR & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.02

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$16.79

Market Cap

234.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
INTT
Founded
2014
1981
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
234.0M
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
BNR
INTT
Price
$9.02
$16.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
10.1K
457.5K
Earning Date
06-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
$66,801,000.00
Revenue This Year
$111.65
$15.82
Revenue Next Year
N/A
$9.10
P/E Ratio
N/A
$284.67
Revenue Growth
N/A
66.06
52 Week Low
$2.80
$6.09
52 Week High
$41.72
$20.00

Technical Indicators

Market Signals
Indicator
BNR
INTT
Relative Strength Index (RSI) 20.79 47.19
Support Level $7.99 $7.44
Resistance Level $9.70 $19.91
Average True Range (ATR) 1.17 1.52
MACD -0.72 -0.21
Stochastic Oscillator 2.40 28.30

Price Performance

Historical Comparison
BNR
INTT

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

Share on Social Networks: